Integrated Proteins Limited has appointed Ms. Shivangi Paliwal as its Company Secretary and Compliance Officer, effective May 31, 2026. The decision follows the resignation of Mr. Girish Kalwani from the positions of Company Secretary and Compliance Officer, which was accepted by the Board effective May 30, 2026. These changes were approved during a Board meeting held on May 30, 2026, at the company's Registered Office.

The resignation of Mr. Girish Kalwani was tendered on May 30, 2026, and took effect from the close of business hours on the same day. The appointment of Ms. Shivangi Paliwal, a qualified Company Secretary with membership number A80556, was made pursuant to the provisions of Section 203 of the Companies Act 2013. She has been designated as Key Managerial Personnel of the company.

Ms. Paliwal is an Associate Member of the Institute of Company Secretaries of India. Her profile describes her as a highly motivated, detail-oriented professional with a strong academic foundation in corporate law, governance, and compliance.

The disclosures regarding the change in Key Managerial Personnel were made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company referenced specific SEBI circulars, including SEBI/HO/CFD/CFD-PoD1/P/CIR/2023/123 dated July 13, 2023, and SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Key Personnel Changes

Integrated Proteins reported a net profit of ₹21.30 lakh for the financial year ended March 31, 2026, compared to ₹22.50 lakh in the previous year. Revenue from operations for FY26 stood at ₹2,152.56 lakh, a significant increase from ₹994.07 lakh in FY25. The board approved the audited standalone financial results during a meeting held on May 26, 2026, at the company's registered office in Jamnagar.

The statutory auditors, M/s B. B. Gusani & Associates, issued an unmodified opinion on the financial results. For the quarter ended March 31, 2026, the company recorded a net profit of ₹23.14 lakh on a total income of ₹569.53 lakh. The earnings per share (EPS) for the year was ₹0.11, compared to ₹0.12 in the previous year.

Financial Performance

The company's total expenses for FY26 amounted to ₹2,125.15 lakh, up from ₹965.74 lakh in the prior year. The profit before tax for the year was ₹27.41 lakh, slightly lower than the ₹28.33 lakh reported in FY25. The finance costs remained nil for both the quarter and the year under review.

Segment-wise Results

Integrated Proteins operates across multiple segments including Agro & Trading, Textile, Securities, and Medical. The Textile segment contributed ₹461.63 lakh to the revenue in the quarter ended March 31, 2026. The Securities segment reported a profit before tax of ₹19.89 lakh for the same period.

Balance Sheet and Cash Flow

The company's equity share capital increased to ₹1,903.02 lakh as of March 31, 2026, from ₹352.02 lakh in the previous year, due to the allotment of shares during the year. Total assets stood at ₹2,061.08 lakh, a decrease from ₹3,237.23 lakh in FY25. The cash and cash equivalents as at the end of the year were negative at ₹(1.56) lakh.

Net cash flow from operating activities for FY26 was ₹360.26 lakh, compared to a net outflow of ₹(2,356.51) lakh in the previous year. The company utilized ₹370.55 lakh in financing activities, primarily due to the repayment of short-term borrowings.